These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1701559)

  • 1. Enzyme activities and protein concentrations in serum of patients with hepatosplenic schistosomiasis.
    Abdel-Rahim IM; Kaiser C; Homeida M; Elsheikh M; Schmidt E; Ehrich JH; Doehring-Schwerdfeger E
    Trop Med Parasitol; 1990 Sep; 41(3):262-4. PubMed ID: 1701559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum type III procollagen peptides in patients with hepatointestinal and compensated hepatoesplenic schistosomiasis forms.
    Mincis M; Braga LL; Russo EM; Novo NF; Juliano Y
    Arq Gastroenterol; 1990; 27(1):24-9. PubMed ID: 1978659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatosplenic schistosomiasis mansoni: a tragic disease].
    de Oliveira-e-Silva A; D'Albuquerque LA
    Arq Gastroenterol; 2003; 40(4):201-2. PubMed ID: 15264039
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoprothrombinemia in the compensated form of hepatosplenic schistosomiasis: further studies.
    Manoukian N; Borges DR
    Rev Inst Med Trop Sao Paulo; 1988; 30(4):274-80. PubMed ID: 3149416
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on certain serum enzymatic activities in hepatosplenic bilharziasis.
    el-Haieg MO; Enein MM; Mustafa MA; el-Khodary MI; Refaat MA; Ibrahim IA; Abul-Fadl MA
    Egypt J Bilharz; 1978; 5(1-2):19-28. PubMed ID: 555751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum trypsin in hepatosplenic schistosomiasis in the Sudan.
    Fedail SS; elMasri SH; Harvey RF
    Trop Med Parasitol; 1990 Dec; 41(4):441-2. PubMed ID: 2075392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prothrombin and prokallikrein in a patient with hepatosplenic schistosomiasis: effects of heparinization and splenectomy].
    Borges DR; Pardini DP; Chehter L
    AMB Rev Assoc Med Bras; 1989; 35(1):39-40. PubMed ID: 2513623
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the cytokines IL-10 and IL-13 as mediators in the progression of Symmers fibrosis in patients with hepatosplenic schistosomiasis mansoni.
    Brandt CT; Rino M; Pitta MG; Muniz JS; Silveira Dde O; Castro CM
    Rev Col Bras Cir; 2010 Oct; 37(5):333-7. PubMed ID: 21180998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum transferrin, albumin and IgG levels in hepatosplenic bilharziasis in Egypt.
    Saif M; Tawfik J; Ali MA; El-Mahrouky SF; Galil N; Galal MN
    J Egypt Med Assoc; 1977; 60(9-12):731-43. PubMed ID: 753855
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations in the fatty acyl composition of plasma cholesteryl esters in Brazilian patients with hepatosplenic schistosomiasis mansoni.
    Gillett MP; Sibrian AM; Dimenstein R; Carvalho VC; Gonçalves MM; Chaves-Filho M
    Braz J Med Biol Res; 1989; 22(8):949-57. PubMed ID: 2517406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet function and the von Willebrand factor antigen in the hepatosplenic form of schistosomiasis mansoni.
    Correia MC; Domingues AL; Lacerda HR; Santos EM; Machado CG; Hora V; Neves MA; Brito A; Coêlho MR; Silva JL
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1053-8. PubMed ID: 19118853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum enzyme tests in hepatosplenic schistosomiasis.
    Mansour MM; Farid Z; Bassily S; Salah LH; Watten RH
    Trans R Soc Trop Med Hyg; 1982; 76(1):109-11. PubMed ID: 6123167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Praziquantel in the treatment of hepatosplenic schistosomiasis: biochemical disease markers indicate deceleration of fibrogenesis and diminution of portal flow obstruction.
    Zwingenberger K; Richter J; Vergetti JG; Feldmeier H
    Trans R Soc Trop Med Hyg; 1990; 84(2):252-6. PubMed ID: 2117787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum laminin in hepatic schistosomiasis.
    Parise ER; Rosa H
    Trans R Soc Trop Med Hyg; 1992; 86(2):179-81. PubMed ID: 1440782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver function and serum protein fractions following abdominal surgery].
    Lundsgaard-Hansen P; Stirnemann H; Frey PE; Riedwyl H
    Schweiz Med Wochenschr; 1969 Nov; 99(44):1589-96. PubMed ID: 4187785
    [No Abstract]   [Full Text] [Related]  

  • 16. [I. Serum transaminase activity in schistosomiasis caused by S. mansoni and S. haematobium].
    Pucci R
    Arch Ital Sci Med Trop Parassitol; 1969; 50(5):143-50. PubMed ID: 5371689
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum glutamyl transferase and other liver function tests in Opisthorchis viverrini infection.
    Pongpaew P; Vudhivai N; Tungtrongchitr R; Schelp FP
    Trop Med Parasitol; 1985 Mar; 36(1):32-4. PubMed ID: 2860715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum enzymes in patients with schistosomiasis mansoni].
    Guimarães RX; Pricoli TI; Novo NF; de Paiva ER
    AMB Rev Assoc Med Bras; 1979 May; 25(5):166-70. PubMed ID: 316555
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease.
    Colley DG; Garcia AA; Lambertucci JR; Parra JC; Katz N; Rocha RS; Gazzinelli G
    Am J Trop Med Hyg; 1986 Jul; 35(4):793-802. PubMed ID: 3089040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of schistosomal portal hypertension.
    Ferraz AA; Bacelar TS; Silveira MJ; Coelho AR; Câmara Neto RD; de Araújo Júnior JG; Ferraz EM
    Int Surg; 2001; 86(1):1-8. PubMed ID: 11890333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.